Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629)
10/1996
10/24/1996CA2216868A1 High efficiency ex vivo transduction of hematopoietic stem cells by recombinant retroviral preparations
10/24/1996CA2215631A1 Arteriovenous and venous graft treatments: methods and compositions
10/23/1996EP0738332A1 Indicator cell line for detecting rna viruses and method therefor
10/23/1996EP0738327A1 Host-vector system for use in gene therapy
10/23/1996EP0738326A1 tfdA GENE SELECTABLE MARKERS IN PLANTS AND THE USE THEREOF
10/23/1996EP0738323A1 Thrombopoietin
10/23/1996EP0738321A1 Association of kinesin with sensitivity to chemotherapeutic drugs
10/23/1996EP0738316A1 Gas permeable bioreactor and method of use
10/23/1996EP0738277A1 Novel proteins which bind to retinoblastoma protein and their encoding dna sequences
10/23/1996EP0646124A4 A genetically engineered cell line for detecting infectious herpes simplex virus and method therefor.
10/23/1996EP0528886B1 Beta cell antigen
10/23/1996EP0365536B1 Biocompatible polyorganosiloxane composition for cell culture apparatus
10/23/1996EP0276262B1 Merozoite surface antigen of plasmodium falciparum
10/23/1996CN1134174A Modified plant viruses as vectors of heterologous peptides
10/23/1996CN1134173A Binding domains from plasmodium vivax and plasmodium falciparum erythrocyte binding proteins
10/23/1996CN1134172A Protocadherin proteins and their uses
10/23/1996CN1134171A DNA coding for phosphoenolpyravate carboxkinase, recombinant vector contg. same, and transgenic plant
10/23/1996CN1134113A Method for inducing antigen-specific T cell tolerance
10/22/1996US5567612 Polymeric matrix provides scaffolding for cell attachment
10/22/1996US5567610 Method of producing human monoclonal antibodies and kit therefor
10/22/1996US5567609 Antigrowth agents
10/22/1996US5567435 Mixing active material with a solution of polymerizable macromer comprising degradable region and free radical polymerizable end groups
10/22/1996US5567425 Plant extracts
10/22/1996CA1338663C Biosynthetic osteogenic proteins and osteogenic devices containing them
10/17/1996WO1996032495A1 Monoclonal antibody specific for human 4-1bb and cell line producing same
10/17/1996WO1996032489A1 Glucose-inducible recombinant viral vector
10/17/1996WO1996032488A1 S-adenosyl-l-homocystein hydrolyse promoter
10/17/1996WO1996032485A1 Phospholipase c homolog
10/17/1996WO1996032483A1 Immune-evading proteins
10/17/1996WO1996032477A1 Genes encoding lymphocyte interferon regulatory factor (lsirf) polypeptides
10/17/1996WO1996032470A1 Method for the preparation and conservation of cellular cultures or parts of cells in the ready state for biological dosages
10/17/1996WO1996032469A1 Method for producing a highly enriched population of osteoclast cells
10/17/1996WO1996032140A1 Methods for engineering artificial veto cells
10/17/1996WO1996032087A2 Transgenic fish in the treatment of diabetes
10/17/1996WO1996032007A1 Transgenic tomato plants containing a fusarium resitance gene
10/17/1996WO1996027006A3 Human vegf-specific antisense oligonucleotides
10/17/1996WO1996023066A3 Prostaglandin receptor, dp
10/17/1996WO1996022375A3 Procedures and materials for conferring disease resistance in plants
10/17/1996WO1996022371A3 C-C CHEMOKINE RECEPTOR 3: CKP-3 OR Eos-L2
10/17/1996CA2217977A1 Immune-evading proteins
10/17/1996CA2217816A1 Method for producing a highly enriched population of osteoclast cells
10/17/1996CA2216858A1 Phospholipase c homolog
10/17/1996CA2215987A1 Glucose-inducible recombinant viral vector
10/17/1996CA2215141A1 Transgenic tomato plants containing a fusarium resistance gene
10/17/1996CA2191969A1 Transgenic fish in the treatment of diabetes
10/16/1996EP0737749A1 Plants with modified stamen cells
10/16/1996EP0737743A1 Thymidine kinase-lacking ouabain-resistant chicken hybridoma
10/16/1996EP0737311A1 Diagnostic, prognostic, and therapeutic methods for solid non-lymphoid tumors and their metastases
10/16/1996EP0737250A1 Humanized antibodies and uses thereof
10/16/1996EP0737247A1 Method and reagent for inhibiting hepatitis c virus replication
10/16/1996EP0737208A1 Monoclonal antibodies specific for phf-tau, hybridomas secreting them, antigen recognition by these antibodies and their applications
10/16/1996EP0601062B1 Sirs vaccine and diagnosis method
10/16/1996EP0432168B1 Genetically engineered coccidiosis vaccine
10/16/1996CN1133599A Recombinant IL4 antibodies useful in treatment of IL4 mediated disorders
10/15/1996US5565356 Hybridoma cell lines which produce monoclonal antibodies having the properties of monoclonal antibody 100-310 and the monoclonal antibodies produced by these hybridoma cell lines
10/15/1996US5565353 Perfusable culture device
10/15/1996US5565350 Compounds and methods for site directed mutations in eukaryotic cells
10/15/1996US5565338 Suppressor T-cell hybridoma and production of allergen specific glycosylation inhibiting factor
10/15/1996US5565337 High fusion tendency, fused with b-cells to produce hybridomas which have increased resistance to death
10/15/1996US5565331 Nucleic acids encoding neural axon outgrowth modulators
10/15/1996US5565321 Isolating nucleic acid, amplifying nucleic acid derived from cd40 ligand gene, determining nucleotide sequence, comparing to standard, determining if protein is expressed which binds cd40
10/15/1996CA2047876C Method and apparatus for investigating and controlling an object
10/15/1996CA2040969C Repopulation of macrophages and granulocytes using transforming growth factor-beta
10/14/1996CA2147062A1 Preserved cell preparations for flow cytometry and immunology
10/10/1996WO1996031780A1 Reagents and methods for the detection and quantification of vancomycin in biological fluids
10/10/1996WO1996031776A1 Multiparameter cell separation using releasable colloidal magnetic particles
10/10/1996WO1996031608A1 Plant pathogen resistance genes and uses thereof
10/10/1996WO1996031607A2 Use of an 'immunodeficiency-virus suppressing lymphokine (isl)' to inhibit the replication of viruses, in particular of retroviruses
10/10/1996WO1996031604A1 Antibodies for the detection of hla-g
10/10/1996WO1996031599A1 Ndf peptides
10/10/1996WO1996031598A1 Tie-2 ligands, methods of making and uses thereof
10/10/1996WO1996031595A1 Cell culture medium
10/10/1996WO1996031548A1 Cell growth substrate polymer
10/10/1996WO1996031538A1 Enrichment for a thymocyte subset having progenitor cell activity using c-kit as a selection marker
10/10/1996WO1996031242A1 RECOMBINANT β-CELL AND USES THEREOF
10/10/1996WO1996031241A1 Transplantation of genetically modified cells having low levels of class i mhc proteins on the cell surface
10/10/1996WO1996031229A1 Inhibiting rejection of a graft
10/10/1996WO1996031225A1 Urinary bladder submucosa derived tissue graft
10/10/1996WO1996031224A1 Immunosuppressant
10/10/1996WO1996031223A1 Method of pretreating viable tissue or cells to be contained within a semipermeable vessel
10/10/1996WO1996031199A1 Pharmaceutical microencapsulation
10/10/1996WO1996021416A3 Methods and compositions for treatment of solid tumors in vivo
10/10/1996WO1996020215A3 Use of mhc-ii binding and/or mhc-ii mimicking molecules for the prevention and/or treatment of inflammatory diseases
10/10/1996WO1996016175A3 Lgmd gene coding for a calcium dependent protease
10/10/1996WO1996014421A3 Tomato fruit promoters
10/10/1996WO1996012009A3 Methods for engineering antigen-presenting cells
10/10/1996WO1994027698A3 Continuous centrifugation process for the separation of biologic components from heterogeneous cell populations
10/10/1996CA2217701A1 Method of pretreating viable tissue or cells to be contained within a semipermeable vessel
10/10/1996CA2217652A1 Recombinant .beta.-cell and uses thereof
10/10/1996CA2217450A1 Use of an "immunodeficiency-virus suppressing lymphokine (isl)" to inhibit the replication of viruses, in particular of retroviruses
10/10/1996CA2217297A1 Transplantation of genetically modified cells having low levels of class i mhc proteins on the cell surface
10/10/1996CA2216880A1 Reagents and methods for the detection and quantification of vancomycin in biological fluids
10/10/1996CA2216406A1 Plant pathogen resistance genes and uses thereof
10/10/1996CA2216359A1 Pharmaceutical microencapsulation
10/10/1996CA2213620A1 Antibodies for the detection of hla-g
10/09/1996EP0736769A1 An assay for determining cyclooxygenase-1 activity
10/09/1996EP0736602A2 Siaalpha 2,3Ga1beta 1, 4G1cNAc alpha 2,8-sialyltransferase
10/09/1996EP0736601A2 Non-A, non-B, non-C, non-D, non-E hepatitis reagents and methods for their use
10/09/1996EP0736169A1 Method for obtaining a cell population enriched in stem cells and compositions derived therefrom
10/09/1996EP0736098A1 Mycobacteria virulence factors and a method for their identification
1 ... 1682 1683 1684 1685 1686 1687 1688 1689 1690 1691 1692 1693 1694 1695 1696 1697 1698 1699 1700 1701 1702 ... 1827